Horstmann, Maximilian
Quarles, C. Derrick Jr.
Happel, Steffen
Sperling, Michael
Faust, Andreas
Rahbar, Kambiz
Clases, David
Karst, Uwe
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC 1450 – 431460824)
University of Graz
Article History
Received: 7 October 2023
Revised: 9 January 2024
Accepted: 11 January 2024
First Online: 30 January 2024
Declarations
:
: The study was approved by the local ethics committee (No. 2007-467-f-S and No. 2016–585-f-S, Ethikkommission der Ärztekammer Westfalen-Lippe und der Universität Münster).
: C. Derrick Quarles is employee of Elemental Scientific Inc. and Steffen Happel is employee of TrisKem International SAS. Kambiz Rahbar reports honoraria from Advanced Accelerator Applications (AAA/Novartis), Bayer, Jahnsen Cielag, Amgen, AstraZeneca, and Pharmtrace and a consultancy/advisory role with ABX GmbH, ABX-CRO, Bayer, and AAA/Novartis and UroTrials. Maximilian Horstmann, Michael Sperling, Andreas Faust, David Clases, and Uwe Karst have no conflicts to declare.